Learn how PCR-based molecular monitoring is accelerating personalized trials in gene therapy, cell therapy, and oncology. Experts from Precision for Medicine, Avidity Biosciences, and Indaptus Therapeutics share insights on generating actionable data and aligning assay design with trial goals.

Topics Covered:

• Optimizing PCR in Clinical Trials: Discover how PCR enables early detection, biological endpoints, patient stratification, and real-time monitoring in oncology, gene and cell therapy trials
• Accelerated Assay Development: Examine factors that enable faster assay development and validation, including reagent availability, platform readiness, and timelines critical to dose escalation studies
• Assay Strategy & Selection: Learn from Precision’s experts about designing, validating, and implementing various qPCR and ddPCR assays to achieve clinical and regulatory milestones while balancing sensitivity and cost
• Applications Across Therapeutic Areas: Understand the latest in PCR technology to measure gene expression, vector copy number, biodistribution, shedding, persistence, replication-competent lentivirus (RCL), and pharmacokinetics (PK) and pharmacodynamic (PD) endpoints
• Case Studies in Action: Hear first-hand from leading biotechnology companies on case studies using scientific innovation to advance novel therapeutic milestones in clinical studies